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The effect of a Homoeopathic complex eye drop solution on the symptoms of 
Computer-induced Asthenopia 
1. Introduction and epidemiology 
Visual display units (VDU’s) such as laptops, tablets, smartphones, computers, game consoles 
and televisions have become an essential part of our modern life both in school and at work 
places (Izquierdo & Townsend, 2008). Up to 90% of computer users may experience visual 
symptoms at one time or another with the use of VDU’s (Barthakur, 2013). Asthenopia 
(eyestrain) is typically associated with near-work and symptoms include dry eyes, eye fatigue 
and difficulty focusing. The major cause of computer-induced asthenopia is fatigue of the ciliary 
and extra-ocular muscles due to prolonged accommodation and vergence required by near-vision 
work (Tiwari et al., 2011). The severity of the symptoms is proportional to the time spent using a 
VDU device and symptoms are substantially reduced after discontinuing usage; even so, the 
symptoms can affect work productivity and quality of life (Barthakur, 2013).  
 
Conventional treatment for asthenopia includes correction of refractive errors, use of 
occupational glasses, eye drops and punctal occlusion (Garin, 2014); ergonomic measures can 
also be helpful (Barthakur, 2013). Homoeopathy is a holistic treatment modality based on the 
“Law of Similars” (Dekkers, 2009). Homoeopathic remedies enhance the body’s own curative 
abilities, enabling the body to heal itself (Ahmad, 2005).  Homoeopathic remedies may provide a 
safe complementary treatment option for asthenopia. The homoeopathic complex eye drop 
solution used in this study consists of Conium maculatum 6X, Natrum muriaticum 6X, Ruta 
graveolens 6X and Senega officinalis 6X. It is a widely available eye drop solution indicated for 
the relief of computer-induced asthenopia. To date, no specific research could be found on the 
effect of this eye drop complex on the symptoms of computer-induced asthenopia.  
 
2. Aim of the study  
 
The aim of the study was to determine the effect of a homoeopathic complex eye drop solution 




3. computer-induced asthenopia 
The number of computer users is increasing rapidly worldwide, with an estimated 1 billion 
people using computers in 2008 (Bhanderi et al., 2008), and 5.3 million computer users in 2006 
in South Africa (Goldstuck & Laschinger, 2006). Between 64% - 90% of computer users will 
experience symptoms of asthenopia and it is likely that this number will increase over the years 
due to increased use (Rosenfield et al., 2010) of electronic devices. In addition to computer 
users, it is estimated that there are over 3 billion internet users in the world 
(Internetlivestats.com, n.d) and 14 million internet users in South Africa (Nevill, 2013). In South 
Africa it is estimated that people spend an average of 431 minutes (7.2 hours) every day looking 
at cell phones, tablets and other VDU’s. That breaks down to 115 minutes spent watching TV, 
126 minutes in front of a computer or laptop, 127 minutes on a smartphone and 63 minutes with 
a tablet (Berthelette, 2014). 
The following factors are associated with an increased incidence of asthenopia: 
 Duration of computer use: most individuals who work on a computer for more than 4 
hours daily experience eye-related discomfort or visual problems;  
 Uncorrected refractive errors: Uncorrected refractive errors compound the problem of 
asthenopia, which may cause added fatigue with computer usage, as the eye fails to bring 
parallel light to the retina;  
 Age >50 years: loss of near focus ability decreases with the increase in age, which further 
leads to symptoms of computer-induced asthenopia;  
 Binocularity dysfunction, accommodation insufficiency or convergence insufficiency 
disorders: the major cause of computer-induced asthenopia is believed to be eye muscle 
fatigue due to prolonged accommodation and vergence demands;  
 Ergonomic factors: improper positioning of the computer may lead to symptoms 
associated with computer-induced asthenopia.  Numerous studies have shown that 
placing a computer monitor below the horizontal plane of the eye increases visual 
comfort; 
 Psychological factors: some complaints of visual health described by VDU workers are 
associated indirectly to psychological distress associated with working conditions; and 
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 Gender: computer-induced asthenopia is more prevalent in females than males (Vilela et 
al., 2015). 
4. Symptoms of computer-induced asthenopia 
Common symptoms of computer-induced asthenopia may include dry eyes (inadequate 
lubrication of the eyes), burning eye pain, itchy or irritated eyes, eye fatigue (failure of the eye to 
accommodate), difficulty focusing (inability to keep a focal point), intermittent double vision 
with near fixation, blurred vision (lack of sharpness of vision resulting in the inability to see fine 
details) and frontal headaches (aching pains localized around or between the eyes) (Amalia et al., 
2010). Individuals with computer-induced asthenopia also complain of photophobia (sensitivity 
to light) and lacrimation (increased secretion of tears) (Akinbinu & Mashalla, 2013). These 
symptoms are temporary and are relieved when resting the eyes (Barthakur, 2013). The 
symptoms described may also be attributed to asthenopia while reading or with normal near 
work. 
 
 5. METHODOLOGY 
5.1 Research sample 
The research sample consisted of 30 participants, male and female, between the ages of 18-35 
years, recruited by means of purposive sampling. Advertisements were placed at the UJ Health 
Clinic, on the Doornfontein campus (Appendix A) with relevant permission granted. 
 
Participants were included in the study if they: 
 Were male or female, between the ages of 18-35; 
 Experienced at least two or more eye-related symptoms of asthenopia (blurred vision, frontal 
headache, dry eyes, photophobia, lacrimation, slow focusing, burning eye pain, itchy or 
irritated eyes, eye fatigue and diplopia) when using a VDU; 
 Used a VDU for a minimum of 3 hours per day; and 
 Experienced eyestrain symptoms for at least one month prior to the study. 
 
Participants were excluded from the study if they: 
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 Used contact lenses; (Contact lenses may compromise tear layer and have an effect on 
symptoms) 
 Was suffering from frequent ocular infections or allergies, glaucoma, cataracts, styes, and 
optic nerve atrophy; 
 Had eye-related problems such as amblyopia, strabismus or uncorrected refractive error; 
 Used medications such as eye drops, anti-histamines, beta-blockers, diuretics, 
antidepressants, hormone replacement therapy, isotretinoin, anticholinergics or 
immunosuppressive drugs; or 
 Had underlying chronic conditions that may result in dry eyes: These may include-  
rheumatoid arthritis, systemic lupus erythematosus, hypothyroidism, omega 3 fatty acid 
deficiency, vitamin A deficiency, Sjogren’s syndrome, scleroderma, connective tissue 
diseases, hepatitis C, undergoing radiation therapy or have had refractive surgery, epilepsy 
or other neurological disorders. 
 Farsightedness more than +1.00D, astigmatism more than -1.00D and myopia of more than 




5.2 Research design and procedure 
This was a randomised, double-blind, placebo-controlled, one-day study. The sample groups 
were shared with another researcher who assessed tear-break up time (TBUT) and used a visual 
analogue scale (VAS) to determine eye discomfort levels. The participants attended an initial 
consultation at the UJ Optometry Clinic. All participants were requested to read the Information 
Form (Appendix B), sign the Participant Consent Form (Appendix C) once they had agreed to 
participate, and complete the Participant Selection Questionnaire to be assessed if they met the 
inclusion and exclusion criteria (Appendix D). All participants who met the criteria were tested 
for any refractive errors present by a qualified optometrist using an autorefractor; they were also 
screened for accommodation and vergence errors. If a participant had any significant uncorrected 
refractive errors, they were referred to a qualified optometrist at the Optometry Clinic and 
excluded from the study. Participants proceeded to the UJ computer lab to play a computer game 
for a two hour period. Participants wearing glasses for reading wore their glasses while using the 
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computer but contact lenses wear was excluded due to reasons mentioned already. After the 2-
hour period, all participants were requested to complete the Symptom Index Questionnaire (SIQ) 
(Appendix E). Participants returned to the computer lab where they were randomly divided into 
two groups. One group received the homoeopathic complex eye drop solution (treatment group) 
and the other group received distilled water (placebo group). They were instructed to place two 
drops into each eye. Participants continued playing the game for a period of 30 minutes, after 
which they completed the SIQ again. 
The homoeopathic complex eye drop solution and distilled water drops were prepared by the 
manufacturer and randomized by an independent person.  Both the treatment and placebo eye 
drops were labelled and packaged in an identical manner in 10ml bottles. Each person selected a 
number and received the corresponding numbered bottle of the medication (or preparation). 
 
5.3 Reliability and validity 
The medication was manufactured using good manufacturing procedures by the manufacturer to 
ensure quality control. Both the placebo and treatment groups received eye drops in identical 
containers; the eye drops were randomized by an independent person. Sheedy et al. (2003) 
suggested that symptom questionnaires should be used in order to measure subjective ocular 
discomfort associated with asthenopia. Currently there is no standardized, validated asthenopic 
symptom questionnaire; most research studies conducted on asthenopia however, make use of a 
numerical grading system. Various studies relating to asthenopia have made use of symptom 
questionnaires, relating specifically to the parameters measured in the study (Rahman & Sanip, 
2011; Shrestha et al., 2011). The Symptom Index Questionnaire was developed by the researcher 
for the purposes of this study and evaluated the following 11 asthenopic symptoms: eye fatigue, 
sore or aching eyes, itchy or irritated eyes, lacrimation, dry eyes, hot or burning eye pain, 
intermittent diplopia at near fixation, blurred vision, photophobia, frontal headache and difficulty 
focusing. Symptom severity was rated by the participant using a 4-point Likert scale where: 0 = 
none, 1 = slightly, 2 = moderately, and 3 = severely. Likert scales are a reliable means of 




5.4. Data collection and analysis 
All data from the questionnaires were statically analysed by means of frequencies and 
descriptives, and non-parametric tests. Inter-group comparisons were done using the Mann-
Whitney U-test. Comparison within the groups (intra-group) was done using the Wilcoxon 
Signed Ranks Test (Kuhudzai, 2015). 
6. Summary: Intra-group analysis 
The Wilcoxon Signed-Ranks test results for the asthenopia symptoms for both the placebo and 
treatment groups. A p-value > 0.05 is considered as non-statistically significant and < 0.05 is 
considered statistically significant. All the symptoms evaluated in the placebo group showed a 
statistical difference as their p values were less than 0.05. In the treatment group only the 
symptoms dry eyes (p=0.096), burning eyes (p=0.180) and frontal headache (p=0.84) showed no 
statistically significant change with a p value of more than 0.05.  
7. Summary: Inter-group analysis 
The Mann-Whitney U test comparing the results before treatment was administrated for both 
groups (time 1) and after the administration of treatment (time 2). All the p values at time 1 are 
greater than 0.05 indicating that the two groups symptoms were very similar before treatment, 
there was no statistical difference between the symptoms before treatment for both groups. At 
time 2 there were statistically significant differences for tearing eyes (p=0.035), frontal headache 
(p=0.020) and difficulty focusing (p=0.036). This indicates that the placebo outperformed the 
treatment groups for these three symptoms, there were no significant differences between the 
groups for any of the other symptoms. Overall the treatment group did not outperform the 
placebo. 
8. Conclusion 
Intra-group analysis revealed that the placebo group showed a significant improvement over time 
of all symptoms evaluated, while the treatment group only improved in 8 of the 11 symptoms. 
Inter-group analysis indicated that there was a statistically significant difference in three 
symptoms (tearing eyes, frontal headache and difficulty focusing) of computer-induced 
asthenopia between the two groups in favour of the placebo group. Therefore it can be concluded 
that the homoeopathic complex eye drop solution was not more effective than the placebo in 
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decreasing the symptoms of computer-induced asthenopia, over a short time period. Future 
studies could make use of a larger sample size and longer duration, and individualised 
homoeopathic treatment could also be investigated. 
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